CCCC
C4 Therapeutics, Inc. · Healthcare · Market cap $417.1M
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$22K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Jul 13, 2026
REYNO LEONARD
C4 Therapeutics, Inc. (CCCC) has 19 SEC Form 4 filings (43 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 13, 2026.
Inside the rolling window, 1 insider at C4 Therapeutics, Inc. reported no open-market purchases and 1 open-market sale totaling $22K. The most recent open-market filing is a sale of 10,000 shares by Chief Medical Officer REYNO LEONARD, dated Jan 16, 2026, worth $22K.
- Industry:Biotechnology
- CEO:Andrew J. Hirsch
- Employees:104
- HQ:Watertown, MA, US
- IPO:2020-10-02
| Source | |||||||
|---|---|---|---|---|---|---|---|
REYNO LEONARDFirst filing | Chief Medical Officer | Sale | 10,000 | $22K | Jan 16 | +52.0% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does CCCC have?
C4 Therapeutics, Inc. (CCCC) has 19 SEC Form 4 filings (43 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Jul 13, 2026.
When was the most recent SEC Form 4 filing for CCCC?
The most recent Form 4 filing for CCCC on Tracefour is dated Jul 13, 2026.
What is the net insider flow at CCCC over the last 6 months?
Over the trailing 180 days, insiders at CCCC have net sold $22K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at CCCC in the current window?
Inside the rolling window, insiders at CCCC bought $0 and sold $22K based on SEC Form 4 filings.
Can I get alerts for CCCC insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at C4 Therapeutics, Inc. (CCCC). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
C4 Therapeutics, Inc. is in the Healthcare sector.